Pemvidutide

No. Pemvidutide is still in clinical development and has not yet received regulatory approval for general prescribing in the UK. It remains under investigation in clinical trials.

Pemvidutide is considered next-generation because it targets more than one hormone pathway involved in metabolism. By activating both GLP-1 and glucagon receptors, it is being studied for its potential to influence appetite, energy balance, and liver health at the same time.

Research is currently exploring pemvidutide’s potential role in reducing liver fat and improving markers associated with metabolic dysfunction. Early data has shown promising signals, but further studies are needed before conclusions can be made.

Most established weight loss injections focus solely on GLP-1 receptor activation. Pemvidutide is designed to stimulate both GLP-1 and glucagon receptors, which may influence not only appetite but also energy expenditure and fat metabolism.

Pemvidutide has progressed through early and mid-stage clinical trials assessing safety, tolerability and effectiveness. Larger studies are ongoing to further evaluate long-term outcomes and confirm its safety profile before any potential approval.

Clinical trials have included adults living with overweight or obesity, as well as individuals with metabolic dysfunction or liver fat accumulation. Final eligibility criteria will depend on future regulatory guidance.

Reported side effects in trials have included gastrointestinal symptoms such as nausea, vomiting and diarrhoea, like other treatments that act on GLP-1 pathways. As research continues, a clearer picture of long-term safety will emerge.

At present, access is generally limited to clinical trial participation. It is not available for routine private prescribing in the UK.

The timeline depends on the outcomes of ongoing clinical trials and regulatory review processes. Even after successful trial results, regulatory approval can take time before a medication becomes widely available.

This depends on your personal health circumstances and weight management goals. Currently licensed treatments have established safety and prescribing guidance. A healthcare professional can help you decide whether beginning an approved treatment now or considering future options is appropriate for you.